SEC Form 4 · accession 0000899243-19-002092
Epizyme, Inc. · EPZM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Beaulieu
Officer — Corporate Controller
Period of report
Jan 24, 2019
Accepted (ET)
Jan 28, 2019 · 8:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001571498
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.12 | Jan 24, 2019 | A | 24,523 | A | — | Jan 23, 2029 | Common Stock | 24,523 | 24,523 | D |
Explanation of responses
- F1This option was granted on January 24, 2019 pursuant to the Company's 2013 Stock Incentive Plan with respect to 24,523 shares of Common Stock, with 25% vesting on January 25, 2020 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.